| Literature DB >> 27115137 |
Jenna B Gillen1, Brian J Martin1, Martin J MacInnis1, Lauren E Skelly1, Mark A Tarnopolsky1,2, Martin J Gibala1.
Abstract
AIMS: We investigated whether sprint interval training (SIT) was a time-efficient exercise strategy to improve insulin sensitivity and other indices of cardiometabolic health to the same extent as traditional moderate-intensity continuous training (MICT). SIT involved 1 minute of intense exercise within a 10-minute time commitment, whereas MICT involved 50 minutes of continuous exercise per session.Entities:
Mesh:
Year: 2016 PMID: 27115137 PMCID: PMC4846072 DOI: 10.1371/journal.pone.0154075
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Subject Characteristics.
| VARIABLE | MICT (10) | SIT (9) | CTL (6) |
|---|---|---|---|
| 28 ± 9 | 27 ± 7 | 26 ± 8 | |
| 176 ± 10 | 177 ± 11 | 176 ± 5 | |
| 84 ± 20 | 84 ± 23 | 78 ± 25 | |
| 26 ± 6 | 27 ± 5 | 25 ± 7 | |
| 33 ± 6 | 32 ± 7 | 32 ± 7 | |
| 2.7 ± 0.5 | 2.6 ± 0.8 | 2.5 ± 0.7 | |
| 248 ± 30 | 243 ± 68 | 219 ± 60 |
Values are means ± S.D. VO2peak, maximal oxygen uptake. No differences were observed between groups at baseline for any variable.
Descriptive Characteristics and Markers of Glycemic Control.
| VARIABLE | MICT (10) | SIT (9) | CTL (6) | STATISTICS | |||||
|---|---|---|---|---|---|---|---|---|---|
| PRE | POST | PRE | POST | PRE | POST | Time | Group | T x G | |
| 84 ± 20 | 82 ± 20 | 84 ± 23 | 83 ± 22 | 78 ± 25 | 78 ± 23 | 0.111 | 0.875 | 0.364 | |
| 26 ± 6 | 26 ± 6 | 27 ± 5 | 26 ± 5 | 25 ± 7 | 25 ± 7 | 0.125 | 0.869 | 0.334 | |
| 27 ± 10 | 25 ± 10 | 30 ± 7 | 28 ± 8 | 24 ± 6 | 25 ± 6 | 0.098 | 0.546 | 0.012 | |
| 2.7 ± 0.5 | 3.2 ± 0.5 | 2.6 ± 0.8 | 3.0 ± 0.7 | 2.5 ± 0.7 | 2.5 ± 0.7 | <0.0001 | 0.338 | <0.0001 | |
| 248 ± 30 | 271 ± 33 | 243 ± 68 | 275 ± 50 | 219 ± 60 | 213 ± 52 | <0.0001 | 0.141 | <0.0001 | |
| 5.0 ± 3.3 | 6.7 ± 5.0 | 4.9 ± 2.5 | 7.5 ± 4.7 | 7.4 ± 5.8 | 7.0 ± 4.9 | 0.006 | 0.841 | 0.039 | |
| 2.0 ± 0.9 | 2.1 ± 0.7 | 2.1 ± 0.9 | 2.4 ± 0.8 | 2.1 ± 0.6 | 2.1 ± 0.7 | 0.119 | 0.822 | 0.576 | |
| 1171 ± 591 | 1007 ± 545 | 1231 ± 705 | 1149 ± 844 | 1095 ± 843 | 1158 ± 908 | 0.338 | 0.956 | 0.353 | |
| 1423 ± 712 | 1223 ± 647 | 1515 ± 917 | 1454 ± 1065 | 1317 ± 946 | 1425 ± 1035 | 0.463 | 0.922 | 0.209 | |
| 321 ± 144 | 257 ± 103 | 303 ± 92 | 225 ± 75 | 201 ± 52 | 222 ± 54 | 0.001 | 0.235 | 0.004 | |
| 5.3 ± 0.8 | 5.7 ± 0.9 | 5.0 ± 1.2 | 5.4 ± 0.8 | 5.5 ± 1.6 | 5.4 ± 0.8 | 0.164 | 0.841 | 0.284 | |
| 10.1 ± 6.0 | 8.4 ± 6.9 | 9.5 ± 5.3 | 7.8 ± 4.1 | 7.5 ± 6.4 | 10.8 ±13.2 | 0.854 | 0.992 | 0.135 | |
| 2.4 ± 1.6 | 2.3 ± 2.1 | 2.1 ± 1.3 | 1.9 ± 1.0 | 2.0 ± 2.3 | 2.7 ± 3.7 | 0.465 | 0.92 | 0.348 | |
| 1.0 ± 0.6 | 1.5 ± 0.6 | 1.0 ± 0.6 | 1.6 ± 0.6 | 1.0 ± 0.4 | 0.9 ± 0.4 | 0.003 | 0.403 | 0.021 | |
Values are means ± S.D. VOpeak, maximal oxygen uptake; CS, insulin sensitivity index from IVGTT; K, glucose rate of disappearance during 10–50 min of IVGTT; ΔAUC, insulin area under the curve from 10–50 min of IVGTT; ΔInsulin AUC, insulin area under the curve from 0–50 min of IVGTT; ΔGlucose AUC, glucose area under the curve from 0–50 min of IVGTT; FPG, fasting plasma glucose; FPI, fasting plasma insulin.
*Significantly different vs. pre-training (p<0.05), as determined by post-hoc analyses following a significant Time x Group interaction (T x G).
Fig 1Effect of SIT and MICT on VO2peak.
Measured at baseline (PRE), 6 weeks (MID), and 12 weeks (POST) in MICT, SIT and CTL. Values are means ± S.D. * p<0.05, vs. same group at PRE; # p<0.05, vs. same group at MID.
Fig 2Effect of SIT and MICT on insulin sensitivity.
The change in insulin sensitivity (CSI) over the 12-week intervention, measured from a 50-minute IVGTT in MICT, SIT and CTL. Closed circles denote individual responses. Values are means ± S.D. * p<0.05, PRE vs. POST.
Fig 3Effect of SIT and MICT on skeletal muscle mitochondrial content.
Measured in muscle biopsy samples obtained from the vastus lateralis before (PRE) and 96 h after (POST) the 12-week intervention in MICT, SIT and CTL. Maximal activity of citrate synthase (A), individual changes in maximal activity of citrate synthase (B) and protein content of various subunits from complexes in the electron transport chain (C). Representative western blots are shown. Values are means ± S.D. * p<0.05, vs. same group at PRE; † p<0.05, vs. CTL at POST.